Готові списки джерел за темами / Jian zhu xue yuan

Добірка наукової літератури з теми "Jian zhu xue yuan"

Автор: Grafiati
Опубліковано: 26 липня 2024
Оновлено: 27 липня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Jian zhu xue yuan".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Jian zhu xue yuan"

1

Li, Zhuo, Liang Qu, Xin Chen, Liu Xue, Jie Li, Qi Liu, Jian Sun, et al. "Abstract 2371: BGB-B167, a first-in-class 4-1BB/CEACAM5 bispecific antibody, exhibits potent in vitro and < for vivo antitumor activity and < for superior safety profile in preclinical models." Cancer Research 84, no. 6_Supplement (March 22, 2024): 2371. http://dx.doi.org/10.1158/1538-7445.am2024-2371.

Повний текст джерела
Анотація:
Abstract 4-1BB (CD137) is a key costimulatory immunoreceptor and a promising therapeutic target in cancer. CEACAM5 (CEA) is a well-established tumor associated antigen overexpressed in many cancers, including colorectal, gastric, lung, pancreatic cancer, liver, breast and thyroid cancers. BGB-B167 is a novel immunoglobulin G (IgG)-based bispecific antibody targeting 4-1BB and CEA and is under clinical development for the treatment of advanced or metastatic solid tumors in humans. BGB-B167 binds to its target proteins with high specificity and affinity. Potent and CEA-dependent functional activities were demonstrated using peripheral blood mononuclear cell (PBMC)-based immune cell activation and cytotoxicity assays. In humanized 4-1BB knock-in mice bearing human CEA-expressing tumors, BGB-B167 exhibited potent, dose-associated single-agent efficacy as well as synergistic antitumor activity in combination with anti-PD-1 antibody. BGB-B167 was well tolerated in 1-month repeat-dose toxicology study in cynomolgus monkeys. Here, we describe the characterization of BGB-B167 with regard to preclinical proof-of-concept and basic drug-like properties. The combined dataset provides an overview on the design, mode of action, preclinical pharmacology and safety profile of BGB-B167. Citation Format: Zhuo Li, Liang Qu, Xin Chen, Liu Xue, Jie Li, Qi Liu, Jian Sun, Hanzi Sun, Yun Chen, Yuanyuan Xie, Wanyi Wang, Lin Zhu, Penghao Wang, Xiaosui Zhou, Hongjia Hou, Jie Chen, Xinyi Liu, Yilu Zhang, Ning Liu, Xinyi Liang, Shuo Zhang, Xiaoyan Tang, Jing Song, Tong Zhang, Xiaomin Song, Xuesong Liu, Kang Li, Chichi Huang. BGB-B167, a first-in-class 4-1BB/CEACAM5 bispecific antibody, exhibits potent in vitro and < for vivo antitumor activity and < for superior safety profile in preclinical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 2371.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

지준호. "A Study on the differentiation and development aspects of Zhu-zi xue - centering around the connection between Huang Gan and Jin-hua school in Yuan period." JOURNAL OF KOREAN PHILOSOPHICAL HISTORY ll, no. 23 (March 2008): 317–47. http://dx.doi.org/10.35504/kph.2008..23.011.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Ma, Xiaowei, Bryan D. Wood, and Brian Way. "Application of Tetraethylsulfamide (TES) As a Cathode Additive in Cylindrical Cells." ECS Meeting Abstracts MA2022-01, no. 2 (July 7, 2022): 357. http://dx.doi.org/10.1149/ma2022-012357mtgabs.

Повний текст джерела
Анотація:
Recently, sulfonamides have been shown to be promising electrolyte components due to their high chemical and electrochemical stability in lithium batteries [1, 2]. The electrolyte stability becomes critical when applying high voltage and/or utilizing Ni-rich layered oxides in high energy density lithium-ion batteries. Another approach to successful Ni-rich cathode performance is to develop a stable and effective cathode electrolyte interphase (CEI). Given the success of sultones and sulfates in this regard [3, 4], it is hypothesized that nitrogen analogs, like sulfonamides, could be tailored to provide a similar benefit. Indeed, Yim et al. [5, 6] have shown that N,N,N’,N’-tetraethylsulfamide (TES) forms a CEI on NMC811 that imparts high voltage cycling stability and less cathode corrosion. Our earlier studies of TES with Ni-rich NCA also formed a favorable CEI and these results are the topic of this presentation. Herein, we examine the performance of 0 - 4 wt.% TES in our commercially available, high power INR18650-P28A. These cells contain a composite SiO/graphite anode in addition to a Ni-rich cathode. As shown in Fig 1, TES significantly decreased the impedance of the cathode interface after conditioning compared to the control electrolyte. Thereafter, cells containing up to 2%TES show improved capacity retention during long-term high-rate cycling (+1C/-80W). Part of this success was due to a suppression of resistance growth during cycling by TES. Fast charge cycling (+3C/-2C), however, was moderately impaired with increased TES. Considering the largely reduced impedance of the cathode, fast-charge performance may have suffered due to anode rate limitations. These results will be discussed as well as gas generation, storage performance, and additional rate and cycling tests. [1] Shuting Feng, Mingjun Huang, Jessica R. Lamb, Wenxu Zhang, Ryoichi Tatara, Yirui Zhang, Yun Guang Zhu, Collin F. Perkinson, Jeremiah A. Johnson, Yang Shao-Horn. Chem, 5, 2630-2641 (2019) [2] Weijiang Xue, Mingjun Huang, Yutao Li, Yun Guang Zhu, Rui Gao, Xianghui Xiao, Wenxu Zhang, Sipei Li, Guiyin Xu, Yang Yu, Peng Li, Jeffrey Lopez, Daiwei Yu, Yanhao Dong, Weiwei Fan, Zhe Shi, Rui Xiong, Cheng-Jun Sun, Inhui Hwang, Wah-Keat Lee, Yang Shao-Horn, Jeremiah A. Johnson, Ju Li. Nature Energy, 6, 495-505 (2021) [3] Koji Abe, Manuel Colera, Kei Shimamoto, Masahide Kondo, Kazuhiro Miyoshi. Journal of Electrochemical Society, 161 (6) A863-A870 (2014) [4] Jian Xia, N. N. Sinha, L. P. Chen, J. R. Dahn. Journal of Electrochemical Society, 161 (3) A264-A274 (2014) [5] Kwangeun Jung, Taeeun Yim. Journal of Alloys and Compounds, 834,155155 (2020) [6] Ji Won Kim, Kwangeun Jung, Taeeun Yim. Journal of Mater. Sci & Tech. 86, 70-76 (2021) Figure 1
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Төрбат, Цагаан. "Ашина овгийн хатны эртний геном нь Хөх түрэгийн хаант улсыг Зүүн хойд Азийн гаралтай болохыг харуулжээ". Mongolian Journal of Anthropology, Archaeology and Ethnology 13, № 1 (10 травня 2024): 141–45. http://dx.doi.org/10.22353/mjaae.20241301013.

Повний текст джерела
Анотація:
Xiao‐Min Yang, Hai‐Liang Meng, Jian‐Lin Zhang, Yao Yu, Edward Allen, Zi‐Yang Xia, Kong‐Yang Zhu, Pan‐Xin Du, Xiao‐Ying Ren, Jian‐Xue Xiong, Xiao‐Yu Lu, Yi Ding, Sheng Han, Wei‐Peng Liu, Li Jin, Chuan‐Chao Wang, and Shao‐Qing Wen. Ancient genome of Empress Ashina reveals the Northeast Asian origin of Göktürk Khanate. – Journal of Systematic and Evolution. Institute of Botany, Chinese Academy of Sciences. 2023. Volume 00 (0) 1-9.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zhou, Lin, Jianguo Sun, Conghua Xie, Youling Gong, Meijuan Huang, Zhiyong Yuan, Lin Wu, et al. "Abstract CT219: Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study." Cancer Research 83, no. 8_Supplement (April 14, 2023): CT219. http://dx.doi.org/10.1158/1538-7445.am2023-ct219.

Повний текст джерела
Анотація:
Abstract Background: The IMpower133 represented the current standard of care in the 1L setting for patients (pts) with ES-SCLC (extensive-stage small cell lung cancer). However, there are still unmet needs for ES-SCLC treatment. LDRT could play a key role in the priming effect of immune system by acting as an immune adjuvant and having sensitive cytotoxic activity to SCLC. The interim analysis of MATCH study after stage I showed promising benefit and tolerability of combination of Atezo + chemotherapy + LDRT in pts with ES-SCLC. Here we report the primary efficacy and safety results of this study. Methods: The MATCH study was a single-arm phase II trial conducted in 8 centers across China. Previously untreated ES-SCLC pts with measureable disease per RECIST v1.1 at baseline, age≥18, ECOG 0-1 were eligible. Atezo (1200 mg IV, D1) + Cisplatin (75 mg/m2 IV, D1)/Carboplatin (AUC = 5 IV, D1) +Etoposide (100 mg/m2 IV, D1-D3) were administrated on a 21-day cycle for four cycles. Concurrent LDRT (15 Gy/5f) were conducted from D1-D5 in the first cycle. Then pts received Atezo maintenance until loss of clinical benefit or unacceptable toxicity. The primary endpoint was objective response rate (ORR), defined as the proportion of patients with a complete response or partial response on two consecutive occasions ≥ 4 weeks apart, as determined by the investigator according to RECIST v1.1. The secondary endpoints included disease control rate (DCR), progression-free survival (PFS), overall survival (OS) and safety. A Simon’s minimax 2-stage design was adopted. Results: As the cutoff date of 30th Nov. 2022, 56 pts have been enrolled. 49 (87.5%) were males; mean age was 58.9 years with 78.6% pts had ECOG PS of 1. 80.4% pts had smoking history. Most pts were staged T4 (n = 33, 58.9%), N3 (n = 37, 66.1%) and M1(n = 40, 71.4%). Median follow-up was 14.8 months (range: 11.6-17.8 m). The confirmed ORR was 87.5% (95% CI: 75.9%-94.8%), all partial response. DCR was 94.6% (95% CI: 85.1%-98.9%). Median PFS was 6.9 m (95% CI: 5.4-9.3 m). The 6-month and 12-month PFS rate were 56.5% and 27.7%. Median OS was not reached (NR, 95% CI: 13.3m, NR). The 12-month OS rate was 71.9%. The safety profile, analyzed in all 56 pts, was consistent with the previous reports. Neutrophil count decreased (60.7%), white blood cell count decreased (58.9%) and platelet count decreased (23.2%) were the most common grade (G) 3-4 adverse events (AE). G5 AE occurred in 1 pt (pneumonia and pulmonary embolism). 4 pts experienced AEs leading to treatment discontinuation. IrAEs were reported in 21 (37.5%) pts, most common irAEs were hyperthyroidism (5.4%) and rash (5.4%). Radiation pneumonitis (G1) was observed in 1 pt. Conclusions: Adding LDRT to Atezo + chemotherapy shows impressive antitumor activity, potential survival benefit and well tolerability in 1L treatment of ES-SCLC. Clinical registration: NCT04622228. Citation Format: Lin Zhou, Jianguo Sun, Conghua Xie, Youling Gong, Meijuan Huang, Zhiyong Yuan, Lin Wu, Hui Wang, Nan Bi, Yaping Xu, Jiang Zhu, Yongmei Liu, Yan Zhang, Min Fan, Bingwen Zou, Min Yu, Yanying Li, Feifei Na, Weigang Xiu, Yong Xu, Jin Wang, Xuanwei Zhang, Jianxin Xue, You Lu. Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl):Abstract nr CT219.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Chao, Xue-lin, Shu-zhen Jiang, Jian-wen Xiong, Jin-qiong Zhan, Bo Wei, Chun-nuan Chen, and Yuan-jian Yang. "Erratum to: Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics." Current Medical Science 40, no. 5 (October 2020): 997. http://dx.doi.org/10.1007/s11596-020-2256-3.

Повний текст джерела
Анотація:
The article “Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics”, written by Xue-lin CHAO, Shu-zhen JIANG, Jian-wen XIONG, Jin-qiong ZHAN, Bo WEI, Chun-nuan CHEN, Yuan-jian YANG was originally published electronically on the publisher’s internet portal on June 2020 without open access. With the author(s)’ decision to opt for Open Choice, the copyright of the article is changed to © The Author(s) 2020 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wei, Heyi, and Wenhua Jiang. "Translation of the ‘Landscape Architecture’ Into Chinese and How to Build the Discipline of Landscape Architecture in China?" International Research in Education 8, no. 1 (February 3, 2020): 104. http://dx.doi.org/10.5296/ire.v8i1.16381.

Повний текст джерела
Анотація:
The translation and connotation of landscape architecture (LA) caused a lot of controversy in academia when the term ‘LA’ was introduced to China. In this study, we summarized the different opinions of Chinese scholars based on the origin, evolution, and professional contents of LA, which can be divided into ‘Jing Guan Jian Zhu’ (Chinese Pinyin), ‘Jing Guan She Ji’, and ‘Feng Jing Yuan Lin’. Finally, this article provides strategies and suggestions for enhancing the development of LA when the first-level discipline is established in China, and the aim is to narrow the gap with the international community.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Song, Runjie, та Lu Gao. "Daiwie Fu 傅大為, STS de yuan qi yu duo zhong jian gou - heng kan jin dai ke xue de yi zhong bian zhi yu da zao STS的緣起與多重建構—橫看近代科學的一種編織與打造 [A Genealogical History of STS and Its Multiple Constructions: To Weave an Extensive Network for Gazing upon the Modern Sciences]". East Asian Science, Technology and Society: An International Journal 15, № 1 (2 січня 2021): 111–18. http://dx.doi.org/10.1080/18752160.2021.1877035.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Yi, Guo, and Martin Lu. "Guodian Bamboo Texts and Pre-Qin Intellectual Thoughts (Guo Dian Zhu Jian Yu Xian Qin Xue Shu Si Xiang)a." Journal of Chinese Philosophy 31, no. 2 (June 2004): 297–301. http://dx.doi.org/10.1111/j.0301-8121.2004.155_1.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Zhu, Xiu-Zhi, Xi Jin, Hu-Yun-Long Zhang, Xiyu Liu, Yi-Fan Zhou, Yi-Yu Chen, Tong Fu, et al. "Abstract PO1-15-07: Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO1–15–07—PO1–15–07. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-15-07.

Повний текст джерела
Анотація:
Abstract Background: The standard approach of using one-size-fits-all endocrine therapy for hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancers has faced significant challenges due to variations in treatment response among individuals. Consequently, there is still an urgent need to understand the molecular biology of HR+/HER2- breast cancer and explore precision treatment strategy. Methods: We established a multiomics cohort (n = 351), multicenter real-world clinical cohorts (n = 643), a prospective clinical cohort (MULAN trial), and a drug-testing platform containing patient-derived organoids (n = 126) and patient-derived tumor fragments (n = 49) of HR+/HER2- breast cancers. Integrating "bench" and “bedside” data, we conducted comprehensive preclinical and clinical translational research on precision strategies in HR+/HER2- breast cancer. Results: We implemented a comprehensive classification system for HR+/HER2- breast cancer, comprising four distinct subtypes. We further demonstrated the efficacy and mechanisms of subtyping-directed precision treatment strategies through clinical cohort studies, omics analysis and functional assays: endocrine therapy alone for the canonical luminal subtype; the addition of CDK4/6 inhibitor and PARP inhibitor for the proliferative subtype; the immunotherapy for the immunogenic subtype; and tyrosine kinase inhibitors for the receptor tyrosine kinase-driven subtype. Using clinically applicable subtyping methods, we validated that matched precision treatment strategies outperformed unmatched approaches in a real-world cohort, almost doubling the median progression-free survival time for patients with refractory advanced HR+/HER2- breast cancer (9.83 months [95% CI, 5.74-13.93] vs 4.77 months [95% CI, 3.35-6.18]; hazard ratio 0.64 [95% CI, 0.41-0.99]). Importantly, the first-stage analysis of the MULAN phase II umbrella clinical trial (NCT04355858) verified the higher objective response rate (88.9%, 95%CI: 51.7%-99.7%) of the subtyping-directed precision treatment. Conclusion: Our study emphasizes the superiority of subtyping-directed precision treatment strategies for HR+/HER2- breast cancer, refines traditional “one-size-fits-all” therapy, and facilitates the translation of precision treatment strategies from bench to bedside. Overall study design Part 1 Subtype Molecular Characteristics: Molecular features of the four subtypes of HR+/HER2- breast cancer. Part 2 Multidimensional Efficacy Validation: Integrating data from a multiomics cohort, real-world study, drug testing platform and prospective clinical research to validate the subtyping-directed precision treatment strategy in HR+/HER2- breast cancer. Part 3 Subtyping-directed Precision Treatment Strategy: Integrating clinical cohort studies, omics analysis and functional assays revealed the heterogeneity of treatment response in HR+/HER2- breast cancer, and proposed a subtyping-directed precision treatment strategy. CIN, chromosomal instability; RTK, receptor tyrosine kinase; CNA, copy-number alteration; ER, estrogen receptor; HR, hormone receptor; HER2, human epidermal growth factor receptor 2. Citation Format: Xiu-Zhi Zhu, Xi Jin, Hu-Yun-Long Zhang, Xiyu Liu, Yi-Fan Zhou, Yi-Yu Chen, Tong Fu, Ming-Liang Jin, Ya-Xin Zhao, Yi-Fan Xie, Ruo-Xi Wang, Zhong-Hua Wang, Lei Fan, Yi-Zhou Jiang, Zhi-Ming Shao. Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2- breast cancer: a sub-study of the MULAN umbrella trial [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO1-15-07.
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Jian zhu xue yuan"

1

Chen, Wenlan. "Bu qi jian pi qu tan fa zhi liao yuan fa xing gao xue ya bing de wen xian yan jiu yu tan tao /." click here to view the abstract and table of contents, 2006. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b19986786a.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jiao, Nina. "Jincheng hua jie gou zhu ci de fen bu he lai yuan : jian lun Shanxi fang yan jie gou zhu ci de ge ju ji xing cheng /." View abstract or full-text, 2006. http://library.ust.hk/cgi/db/thesis.pl?HUMA%202006%20JIAO.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Yung, Kong-sing. "A comparative study of Wei Yuan's Haiguo Tuzhi and Xu Jiyu's Yinghuan Zhilue Wei Yuan "Hai Guo tu zhi" yu xu ji yu "Ying Huan zhi lüe" bi jiao yan jiu /." Click to view the E-thesis via HKUTO, 2001. http://sunzi.lib.hku.hk/hkuto/record/B31953359.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zhang, Shifei. "Shanghai ai zheng zi zhu zu zhi yan jiu zu yuan can yu, she hui zhi chi he she hui xue xi de zeng quan xiao guo /." online access from Digital dissertation consortium, 2001. http://libweb.cityu.edu.hk/cgi-bin/er/db/ddcdiss.pl?3025931.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lau, Wai-hung. "The establishment of an electronic portfolio for Chinese language favours the development of students' language ability Wei Zhongguo yu wen ke jian dian zi hua xue xi li cheng dang an you zhu xue sheng yu wen neng li fa zhan /." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B40039973.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

To, Suk-kwan. "The effectiveness of a reading module in enhancing junior students' reading motivation and conceptual knowledge Ti sheng chu zhong xue sheng yue du dong ji ji wen hua zhi shi dan yuan jiao xue cheng xiao yan jiu /." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B40039985.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wang, Xiaoning. "Zhongguo gao deng yuan xiao zhu fang zheng ce : Beijing Qing hua da xue ge an yan jiu = Housing policy in China's higher education institutes : a case study of Tsinghua University in Beijing /." click here to view the abstract and table of contents, 1998. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b17040747a.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Liao, Yi-Chun, and 廖羿鈞. "A Study of Yuan Haowen’s “ Xu Yi Jian Zhi ”." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/27655869416256639611.

Повний текст джерела
Анотація:
碩士
國立雲林科技大學
漢學資料整理研究所碩士班
99
The research of Xu Yi Jian Zhi not only revolves around Yi Jian Zhi but also has everything to do with the life background of Yuan Haowen. Overall, the life of Yuan Haowen can be roughly divided into three periods. The first period, happening under Yuan’s age of twenty, serves as the brewing phase. The second period, from twenty-one to forty-two years old, is referred to as the active phase. The third period, from forty-three to sixty-eight years old, is thought to be latent phase. The completion of the book entitled Xu Yi Jian Zhi spans from 1215 to 1257. In principle, the volume and content is basically the same no matter in the transcription or the original manual. Today, the widely-adopted De Yue Yi Cong Shu Ben contains 203 chapters. The disparity from the transcription lies in volume Two called Yan Shou Dan. Based on the transcription in Ching Dynasty, volume Two includes Yan Shou Dan as well as Chu Jian Fang. As a result, excluding the missing four articles, Xu Yi Jian Zhi actually includes either 203 or 204 chapters. However, the source of a vast majority of materials are adopted from Yuan Haowen’s writing, such as Jung Jou Ji, Zhong Zhou Ji, or drawn on the missing books like Yuan Shi Ji Yan Fang or Ren Chen Za Bian. In general, among the relevant collections of Yuan Haowen’ s literary creation, Xu Yi Jian Zhi falls into the category of supernatural fiction infused with historical sources along with miscellaneous notes. From the angle of history, this book, which is tantamount to Zhong Zhou Ji and Ren Chen Za Bian documented in Jin Shin, is actually sprinkled with historical materials belonging to Jin Dynasty. Against the backdrop of coexistence between Song Dynasty and Jin Dynasty, Yuan Haowen’s burning eagerness to preserve historical materials is piqued after the collapse of Jin Dynasty. Therefore, all aspects of the situations are truthfully chronicled in the book, Xu Yi Jian Zhi. Nevertheless, due to the complicatedly convoluted content, little research is conducted on this book. Therefore, without changing the tile of the book, Xu Yi Jian Zhi inherits the underlying purpose of Yi Jian Zhi and attempts to outshine its accomplishment. As a consequence the thesis aims to carry out the study on Xu Yi Jian Zhi and delves into the undiscovered value of content to some extent.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Ying-TzuLin and 林纓姿. "A Study on Diao Yuan Hu Ke and His NovelYuan Zhu Zhi Yu Xue Chuang Tan Yi." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/4az3av.

Повний текст джерела
Анотація:
碩士
國立成功大學
中國文學系
102
Diao Yuan Hu Ke’s Yuan zhu zhi yu xue chuang tan yi was one of the wenyan zhiguai fictions of short stories in Ming Dynasty. There were totally thirty stories in this book. The book was separated into two parts: the first part comprised sixteen stories and the second part included fourteen stories. Among these thirty stories, Tianfudianjulu and Dengyaoyehualu had lost their contents and only remained the titles. In the early history of Chinese literature and classical fictions, there was little discussion on Yuan zhu zhi yu xue chuang tan yi because it was a rare and uncommon fiction that few people would know. Nevertheless, according to the information and materials we have now, after Yuan zhu zhi yu xue chuang tan yi was published, more than twenty-five stories were included in the books such as Hushicuibian, Guosetianxiang, Xiuguchunrong, Wanjingqinglin, Yanjubiji, Guang Yan Yi Bian, Xu Yan Yi Bian, History of Love, Gujinqingtanwanxuan, and You han bai bian, which showed that Yuan zhu zhi yu xue chuang tan yi was really a popular fiction during the time. However, the original version of Yuan zhu zhi yu xue chuang tan yi had long been disregarded and was lost for more than four hundred years. Not until the end of twentieth century was the book re-published and re-proofread by Jilin University Press and Zhonghua Bookstore and therefore the book could be continued passing to the generation again. Thereafter, Zhonghua editorial department again tried to look for two lost stories, Tianfudianjulu and Dengyaoyehualu, inferring that “Toutaoji” in Guang Yan Yi Bian and “Dengshenyehua” in Gujinqingtanwanxuan should be the lost tales. For these reasons, when the book was republished again, the details of these two stories were given in Appendix at the end of the book. That is to say, readers now could see the complete thirty stories in Yuan zhu zhi yu xue chuang tan yi. The book was written by the background of Jiaxing and through the people and things in Jiaxing, Diao Yuan Hu Ke in his book used metaphors and analogies to praise and criticize on the basis of indoctrination, exhortation, and moralizing. In other words, it was really a fiction filled with local color and promoting virtues and punishing evils. There are six chapters in the thesis. The first chapter illustrates the motivation and research goals and reviews the related literary papers of Diao Yuan Hu Ke and Yuan zhu zhi yu xue chuang tan yi in order to see how critics has investigated it. The chapter also demonstrates the methods and outline of the thesis. Furthermore, through the identity of Diao Yuan Hu Ke, historical background, and the situation of how Yuan zhu zhi yu xue chuang tan yi is included in other books and the year of publication, the second chapter goes on to undertake a more complete research on and explanation for the book. The third chapter mainly focuses on the analysis of the stories in Yuan zhu zhi yu xue chuang tan yi. According to the synopsis of stories, the book can be divided into three kinds of topics involving love, warning, and praise in songs. The fourth chapter looks into the details of characters shaping in Yuan zhu zhi yu xue chuang tan yi so as to summarize the typical characters that Diao Yuan Hu Ke aims to present and moreover addresses the narrative point of view, the performance of poetry, as well as the ideological contents of the topics that the book wishes to express for its readers. The following chapter continues to discuss the situation of a historical transition that forms a bridge between earlier and later stages. It first investigates the origins of the stories in order to have the in-depth understanding of inheritance and innovation of the stories. Besides, the chapter also tried to compare the similarities and differences between the earlier and later development and extension of the stories. Then, the chapter goes on to see how Diao Yuan Hu Ke weeds through the old to bring forth the new based on the original stories of similar themes to present the different types of stories. After that, this chapter steps forward to do the research on the circumstances of how Yuan zhu zhi yu xue chuang tan yi could influence the writing of fictions in the late Ming and early Qing Dynasty. In conclusion, according to the previous five chapters, the sixth chapter aims to summarize the results and contribution of this study, confirm the value and particularity of Yuan zhu zhi yu xue chuang tan yi, regard Yuan zhu zhi yu xue chuang tan yi as a link to carry on the past heritage and open up the future in the history of Chinese fictions, and moreover indicate its all-out effort to promote the local culture during the time.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

"香港教師團體的國民教育觀: 教協及教聯的符號學比較分析". 2006. http://library.cuhk.edu.hk/record=b5896490.

Повний текст джерела
Анотація:
李紹宏.
"2006年8月"
論文(哲學碩士)--香港中文大学, 2006.
參考文獻(leaves 243-262).
"2006 nian 8 yue"
Abstracts in Chinese and English.
Li Shaohong.
Lun wen (zhe xue shuo shi)--Xianggang Zhong wen da xue, 2006.
Can kao wen xian (leaves 243-262).
Chapter 第一章： --- 導言 --- p.1
Chapter 1.1 --- 研究背景：香港政治文化與國民教育取向 --- p.2
Chapter 1.2 --- 教師團體 --- p.7
Chapter 1.2.1. --- 教協簡介 --- p.7
Chapter 1.2.2 --- 教聯簡介 --- p.9
Chapter 1.3 --- 過渡期的政治變化與國民教育的關係 --- p.11
Chapter 1.4 --- 回歸前後的國民教育議題論爭 --- p.16
Chapter 1.5 --- 研究意義 --- p.33
Chapter 1.6 --- 章節安排 --- p.34
Chapter 第二章： --- 硏究理論 --- p.36
Chapter 2.1 --- 「民族主義」簡介 --- p.36
Chapter 2.2 --- 「中國」分析-回應西方民族主義理論 --- p.39
Chapter 2.2.1 --- 對「中國」的質疑 --- p.40
Chapter 2.2.2 --- 杜贊奇與葛兆光等理論 --- p.42
Chapter 2.2.3 --- 「文化中國」的認同 --- p.47
Chapter 2.2.4 --- 小結 --- p.49
Chapter 2.3 --- 身份認同 --- p.49
Chapter 2.3.1 --- 有關「身份認同」 --- p.50
Chapter 2.3.2 --- 有關「民族認同」 --- p.51
Chapter 2.4 --- 中國民族主義：對外戰爭與「創傷記憶」的民族意識 --- p.54
Chapter 2.5 --- 「創傷記憶」與「驕傲盛世」回憶的民族主義--中國人身份的回溯 --- p.58
Chapter 第三章： --- 研究設計 --- p.64
Chapter 3.1 --- 硏究問題 --- p.64
Chapter 3.2 --- 硏究起點 --- p.65
Chapter 3.3 --- 硏究對象 --- p.67
Chapter 3.3.1 --- 《教協報》及《香港教育》簡介 --- p.67
Chapter 3.3.2 --- 本硏究的選材及標記 --- p.67
Chapter 3.4 --- 硏究方法 --- p.68
Chapter 3.4.1 --- 質化研究法(Qualitative research) --- p.68
Chapter 3.4.2 --- 符號學分析方法 --- p.69
Chapter 第四章、 --- 神話的建立過程-對外仇恨的民族主義與國民教育（一） --- p.82
Chapter 4.1 --- 引言 --- p.82
Chapter 4.2 --- 教協 --- p.83
Chapter 4.2.1 --- 反日愛國與符號分析 --- p.83
Chapter 4.2.2 --- 反日與國民教育 --- p.89
Chapter 4.3 --- 教聯 --- p.92
Chapter 4.3.1 --- 反日愛國與符號分析 --- p.92
Chapter 4.3.2 --- 反日與國民教育 --- p.94
Chapter 4.4 --- 小結 --- p.96
Chapter 第五章、 --- 神話的建立過程-對外仇恨的民族主義與國民教育(二） --- p.99
Chapter 5.1 --- 引言 --- p.99
Chapter 5.2 --- 教協 --- p.99
Chapter 5.2.1 --- 反日愛國與符號分析 --- p.100
Chapter 5.2.2 --- 反日與國民教育-理性神話 --- p.103
Chapter 5.3 --- 教聯 --- p.107
Chapter 5.3.1 --- 反日愛國與符號分析 --- p.107
Chapter 5.3.2 --- 反曰與國民教育 --- p.108
Chapter 5.4 --- 小結 --- p.109
Chapter 第六章 --- 三個神話的確立 --- p.112
Chapter 6.1 --- 文字及圖片分析 --- p.112
Chapter 6.1.1 --- 系譜軸(Paradigm) --- p.112
Chapter 6.1.2 --- 毗鄰軸(Syntagm) --- p.113
Chapter 6.2 --- 歌曲及語言分析 --- p.118
Chapter 6.2.1 --- 歌曲介紹 --- p.119
Chapter 6.2.2 --- 符號分析 --- p.124
Chapter 6.3 --- 三個神話的建立 --- p.130
Chapter 6.3.1 --- 神話的建構過程 --- p.130
Chapter 6.3.2 --- 神話的延伸 --- p.136
Chapter 6.4 --- 小結 --- p.140
Chapter 第七章： --- 血緣神話認同-八九民運 --- p.144
Chapter 7.1 --- 引言 --- p.144
Chapter 7.2. --- 教協愛國及民主想像 --- p.144
Chapter 7.3. --- 教聯黨國不分的矛盾 --- p.157
Chapter 7.3.1 --- 對中共的批評與隱晦 --- p.159
Chapter 7.3.2 --- 「自我失語」與「失憶」的教聯六四歷史 --- p.164
Chapter 7.3.3 --- 教導六四史的方法--客觀理性的歷史教育還是失憶教育？ --- p.166
Chapter 第八章 --- 回蹄神話(一）教聯 --- p.174
Chapter 8.1 --- 引言 --- p.174
Chapter 8.2 --- 民族恥´辱ؤ道德與回歸 --- p.177
Chapter 8.3 --- 奴化教育-救贖與回歸 --- p.186
Chapter 第九章 --- 回歸神話（二)教協 --- p.201
Chapter 9.1 --- 引言 --- p.201
Chapter 9.2 --- 民族恥辱-道德與回歸 --- p.201
Chapter 9.3 --- 回歸矛盾-血緣神話 --- p.205
Chapter 9.4 --- 小結-教聯及教協回歸的取態 --- p.216
Chapter 第十章 --- 結論 --- p.225
Chapter 10.1 --- 總結--回應第一個問題 --- p.225
Chapter 10.2 --- 後現代的質疑 --- p.226
Chapter 10.3 --- 批判與國民教育-回應問題二 --- p.229
Chapter 10.4 --- 研究的起點與啓示-民族身份的反思、教師的反省 --- p.233
Chapter 10.5 --- 硏究的貢獻、限制與啓發 --- p.236
Chapter 10.5.1 --- 硏究的貢獻及特色 --- p.237
Chapter 10.5.2 --- 研究限制 --- p.237
Chapter 10.5.3 --- 未及的討論 --- p.240
Chapter 10.6 --- 後記 --- p.241
參考資料 --- p.243
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Jian zhu xue yuan"

1

lu, Hu ren. Ju zhu jian zhu she ji yuan li. Bei jing: Zhong guo jian zhu gong ye chu ban she, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jian zhu li cheng: Traces in architecture : jian zhu li shi.jian zhu li lun.jian zhu ping lun, cong yuan gu shi qi dao wen yi fu xing. Tai bei shi: Tian yuan cheng shi wen hua, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Zheng zhi jing ji xue yuan zhu jian ming jiao cheng. [Canton]: Guangdong gao deng jiao yu chu ban she, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zhu zhai jian zhu she ji yuan li. Beijing Shi: Gao deng jiao yu chu ban she, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ge, Liu, ed. Jian zhu mei xue gou tu yuan li. Beijing: Zhongguo jian zhu gong ye chu ban she, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Beijing gong ye da xue jian zhu gong cheng xue yuan. Beijing gong ye da xue jian zhu gong cheng xue yuan yuan zhi (1960-2010). [Beijing: Beijing gong ye da xue jian zhu gong cheng xue yuan, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

bian, Wei Hongyang Zhu, and Long Hao Zhu bian, eds. Zhu zhai jian zhu she ji yuan li: The design theory of residential buildings. 3rd ed. Beijing: Zhong guo jian zhu gong ye chu ban she, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Zhongguo wen hua da xue. Zhongzheng tu shu guan. Zhongguo wen hua da xue jiao zhi yuan zhu zuo mu lu: Qing zhu jian xiao 30 zhou nian. Daibei Shi: Zhongguo wen hua da xue tu shu guan, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Zongrong, Fu, ed. Jiao shi jian zhu hua yu mei shu zuo pin ji. Beijing: Zhongguo jian zhu gong ye chu ban she, 1997.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Jinan da xue. Wen xue yuan. Qing zhu Jinan da xue jian xiao ba shi zhou nian wen xue yuan ke xue lun wen xuan ji. Guangzhou: Jinan da xue, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "Jian zhu xue yuan" для конкретних типів джерел:
Статті в журналах Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії